Meet
Features
Solutions
Pricing
Sales Intelligence
Qualify prospects and connect with decision makers effortlessly
Research Companies & Directors
Make important decisions with absolute confidence
Create B2B Marketing Lists
Target and reach more of your ideal prospects than ever
Monitor Risks & Opportunities
Be the first to learn about changes in the companies that matter
Cleanse Your B2B Database
Instantly transform old records into new opportunities
Perform KYC Checks
Completely understand who you're working with
Discover New Businesses
Identify and connect with new companies as soon as they register
Company Credit Reports
See how companies are performing year–on–year and explore their debts
UPGRADE
Contact
Credit Report
Financials
People
Ownership
Latest Activity
Mutual Companies
Documents
Repayment History
Genome Therapeutics Ltd
Genome Therapeutics Ltd is an active company incorporated on 8 January 2020 with the registered office located in London, Greater London. Genome Therapeutics Ltd was registered 6 years ago.
Watch Company
Status
Active
Active since
incorporation
Company No
12392992
Private limited company
Age
6 years
Incorporated
8 January 2020
Size
Micro
Turnover is under
£1M
Balance sheet is under
£500,000
Under
10 employees
Confirmation
Due Soon
Dated
7 January 2025
(1 year ago)
Next confirmation dated
7 January 2026
Due by
21 January 2026
(13 days remaining)
Last change occurred
12 months ago
Accounts
Submitted
For period
1 Jul
⟶
30 Jun 2025
(12 months)
Accounts type is
Small
Next accounts for period
30 June 2026
Due by
31 March 2027
(1 year 2 months remaining)
Learn more about Genome Therapeutics Ltd
Contact
Update Details
Address
Regent House
316 Beulah Hill
London
SE19 3HF
United Kingdom
Same address since
incorporation
Companies in SE19 3HF
Telephone
Unreported
Email
Unreported
Website
Inflexafrica.co.ke
See All Contacts
People
Officers
5
Shareholders
8
Controllers (PSC)
1
Dr James Walter Glasheen
Director • Ceo • American • Lives in England • Born in Dec 1967
Dr Bobby Satyadev Yerramilli-Rao
Director • Investor • Lives in UK • Born in May 1966
Dr Samuel Aparicio
Director • None • Canadian • Lives in Canada • Born in Oct 1963
Dan McHugh
Director • Investor • American • Lives in United States • Born in Mar 1992
Saul Charles Klein
Director • British • Lives in UK • Born in Oct 1970
See Key People
Shareholders, PSCs & Group Structure
See who truly controls a company with full PSC, Shareholder, and Group Structure exploration
See All Shareholders, PSCs & Group Structure
Mutual Companies
Faculty Science Limited
Saul Charles Klein is a mutual person.
Active
Zinc Ventures Limited
Saul Charles Klein is a mutual person.
Active
Phoenix Court Spaces Limited
Saul Charles Klein is a mutual person.
Active
Phoenix Court Group Limited
Saul Charles Klein is a mutual person.
Active
The Manchester Academy Ltd
Saul Charles Klein is a mutual person.
Active
Phoenix Court Works Limited
Saul Charles Klein is a mutual person.
Active
Newton Venture Education Limited
Saul Charles Klein is a mutual person.
Active
The Next Economy Works Limited
Saul Charles Klein is a mutual person.
Active
See All Mutual Companies
Financials
Net Assets, Total Assets & Total Liabilities (2021–2025)
Period Ended
30 Jun 2025
For period
30 Jun
⟶
30 Jun 2025
Traded for
12 months
Cash in Bank
£362.94K
Decreased by £1.11M (-75%)
Turnover
Unreported
Same as previous period
Employees
6
Same as previous period
Total Assets
£642.86K
Decreased by £1.39M (-68%)
Total Liabilities
-£278.02K
Decreased by £44.45K (-14%)
Net Assets
£364.84K
Decreased by £1.34M (-79%)
Debt Ratio (%)
43%
Increased by 27.36% (+172%)
See 10 Year Full Financials
Latest Activity
Dr James Walter Glasheen Appointed
2 Months Ago on 20 Oct 2025
Notification of PSC Statement
2 Months Ago on 16 Oct 2025
Small Accounts Submitted
3 Months Ago on 6 Oct 2025
Dr Samuel Aparicio Appointed
3 Months Ago on 14 Sep 2025
Shankar Balasubramanian Resigned
3 Months Ago on 14 Sep 2025
Samuel Aparicio (PSC) Resigned
5 Months Ago on 8 Aug 2025
Shankar Balasubramanian (PSC) Resigned
5 Months Ago on 8 Aug 2025
Mr Saul Charles Klein Appointed
5 Months Ago on 8 Aug 2025
Shares Cancelled
11 Months Ago on 5 Feb 2025
Own Shares Purchased
11 Months Ago on 4 Feb 2025
Get Alerts
Get Credit Report
Discover Genome Therapeutics Ltd's Credit Score, how much credit you can offer them, and how likely they are to repay you
See All Credit Score & Limits
Documents
Resolutions
Submitted on 18 Dec 2025
Memorandum and Articles of Association
Submitted on 18 Dec 2025
Statement of capital following an allotment of shares on 26 November 2025
Submitted on 11 Dec 2025
Resolutions
Submitted on 28 Oct 2025
Appointment of Dr James Walter Glasheen as a director on 20 October 2025
Submitted on 27 Oct 2025
Statement of capital following an allotment of shares on 20 October 2025
Submitted on 25 Oct 2025
Notification of a person with significant control statement
Submitted on 16 Oct 2025
Appointment of Dr Samuel Aparicio as a director on 14 September 2025
Submitted on 8 Oct 2025
Termination of appointment of Shankar Balasubramanian as a director on 14 September 2025
Submitted on 7 Oct 2025
Accounts for a small company made up to 30 June 2025
Submitted on 6 Oct 2025
Explore All Documents
Repayment History
Understand how businesses repay their debts and see how they're performing year‐on‐year
See All Charges & CCJs